Clinical Trials Browser

Mesothelioma, Malignant

NCT02797795 2026-05-13

A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers

Phase 1 Completed

78 enrolled

Other solid neoplasm

Advanced Cancer

NCT05038839 2026-05-12

Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors

Phase 1 Completed

44 enrolled

Other solid neoplasm

Advanced Malignant Solid Neoplasm

NCT05162755 2026-05-12

S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers

Phase 1 Completed

41 enrolled

Other solid neoplasm

Solid Tumor

NCT05387928 2026-05-08

A Study of KL340399 in Patients With Advanced Solid Tumors

Phase 1 Completed

21 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05549804 2026-05-08

A Study of Intratumoral KL340399 in Patients With Advanced Solid Tumors

Phase 1 Completed

6 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT04380753 2026-05-06

AMG 510 Ethnic Sensitivity Study (CodeBreaK 105).

Phase 1 Completed

12 enrolled 12 charts

Other solid neoplasm

Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation

NCT04457778 2026-05-04

First in Human Study of M6223

Phase 1 Completed

58 enrolled 38 charts

Other solid neoplasm

Metastatic Solid Tumors

NCT05824663 2026-05-04

A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of HBM1020 in Subjects With Advanced Solid Tumors

Phase 1 Completed

17 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT07554196 2026-04-28

A Phase 1 Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HH-101 in Patients With Advanced Solid Tumors

Phase 1 Completed

12 enrolled

Other solid neoplasm

Solid Tumor

NCT05085548 2026-04-27

ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies

Phase 1 Completed

46 enrolled

GastrointestinalOther solid neoplasm

Advanced Pancreatic Cancer

NCT03317743 2026-04-17

Study to Assess the Safety & Tolerability of NOV140101(IDX-1197) in Patients With Advanced Solid Tumors

Phase 1 Completed

32 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT03881488 2026-04-17

Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies

Phase 1 Completed

100 enrolled

DermatologicHead & NeckOther solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Melanoma, Mesothelioma, Neoplasm Metastasis, Small Cell Lung Carcinoma

NCT04375267 2026-04-14

LuPARP

Phase 1 Completed

18 enrolled

EndocrineNETOther solid neoplasmThoracic

Mesothelioma, Thymoma, Neuroendocrine Tumors

NCT04303858 2026-04-01

A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors

Phase 1 Completed

189 enrolled

Other solid neoplasm

Solid Tumors

NCT05848466 2026-03-30

Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients

Phase 1 Completed

23 enrolled

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT03678350 2026-03-27

Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery

Phase 1 Completed

9 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Pleural Diseases

NCT02215720 2026-03-20

TORERO

Phase 1 Completed

45 enrolled

Other solid neoplasm

Patients With Advanced or Metastatic Solid Tumors

NCT04158336 2026-03-18

A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors

Phase 1 Completed

274 enrolled

Other solid neoplasm

Solid Tumor

NCT06056024 2026-03-17

A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Phase 1 Completed

47 enrolled

Other solid neoplasm

Solid Tumor, KRAS Mutation

NCT04261413 2026-03-11

Phase Ia/Ib Study of RS-0139 in Patients With a Recurrent, Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

16 enrolled

Other solid neoplasm

Solid Tumors

NCT05735366 2026-03-10

A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

22 enrolled

Other solid neoplasm

Solid Tumor

NCT02617277 2026-03-04

Safety, Tolerability and Pharmacokinetics of AZD1775 (Adavosertib) Plus MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumours

Phase 1 Completed

56 enrolled

Other solid neoplasm

Advanced Solid Tumours

NCT05800964 2026-02-17

Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors

Phase 1 Completed

37 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT02122913 2026-02-05

A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer

Phase 1 Completed

75 enrolled 2 FDA

Other solid neoplasm

Solid Tumors Harboring NTRK Fusion

NCT05478486 2026-02-04

Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours

Phase 1 Completed

7 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05372367 2026-02-03

A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor

Phase 1 Completed

33 enrolled

Other solid neoplasm

Solid Tumors

NCT02856425 2026-01-20

PEMBIB

Phase 1 Completed

196 enrolled

Other solid neoplasm

Patients With Any Advanced Solid Tumors

NCT04587479 2026-01-13

A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors

Phase 1 Completed

41 enrolled

Other solid neoplasm

Solid Tumors, Adult

NCT04501276 2026-01-08

A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients

Phase 1 Completed

72 enrolled

Other solid neoplasm

Advanced/Metastatic Solid Tumors

NCT03905148 2026-01-07

Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors

Phase 1 Completed

91 enrolled

Other solid neoplasm

Solid Tumor, Adult

NCT06130722 2026-01-07

First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study

Phase 1 Completed

18 enrolled

Other solid neoplasm

Locally Advanced/Metastatic Solid Tumors

NCT04617314 2026-01-06

A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors

Phase 1 Completed

67 enrolled

Other solid neoplasm

Solid Tumor

NCT05378737 2026-01-06

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection

Phase 1 Completed

216 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05864573 2026-01-05

Study of ZGGS15 in Patients With Advanced Solid Tumors

Phase 1 Completed

22 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT01282697 2025-12-22

RAPIRI

Phase 1 Completed

42 enrolled

Other solid neoplasm

Refractory Solid Tumors in Children

NCT04936178 2025-12-22

A Study of NB003 in Patients With Advanced Malignancies

Phase 1 Completed

258 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT03388632 2025-12-18

Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers

Phase 1 Completed

31 enrolled 20 charts

Other solid neoplasm

Metastatic Solid Tumors

NCT05240898 2025-12-18

A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors

Phase 1 Completed

116 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05287399 2025-12-18

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors

Phase 1 Completed

18 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05105971 2025-12-08

Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumor Patients in China

Phase 1 Completed

30 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05155722 2025-12-08

Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT1308 in Advanced Solid Tumors

Phase 1 Completed

59 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT06001580 2025-11-21

A Study of BR101 Injection Alone in Subjects With Advanced Solid Tumors

Phase 1 Completed

15 enrolled

Other solid neoplasm

Advanced Solid Tumor

NCT05322408 2025-11-05

HCW9218 in Select Advanced Solid Tumors

Phase 1 Completed

18 enrolled 17 charts

Other solid neoplasm

Solid Tumor

NCT04362748 2025-10-07

Study of AMG 256 in Adult Subjects With Advanced Solid Tumors

Phase 1 Completed

34 enrolled

Other solid neoplasm

Advanced Solid Tumors

NCT05072106 2025-09-16

Study to Evaluate the Effect of Bosentan on the Pharmacokinetics of Lurbinectedin in Patients With Advanced Solid Tumors

Phase 1 Completed

11 enrolled 26 charts

Other solid neoplasm

Advanced Solid Tumor

NCT05109832 2025-09-16

A Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]IMP4297 to China Healthy Male Subjects

Phase 1 Completed

6 enrolled

Other solid neoplasm

Solid Tumor

NCT05390944 2025-09-16

An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fasting Condition

Phase 1 Completed

28 enrolled

Other solid neoplasm

Solid Tumor

NCT05391048 2025-09-16

An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fed Condition

Phase 1 Completed

36 enrolled

Other solid neoplasm

Solid Tumor

NCT05989997 2025-09-16

Phase I Clinical Trial of 68Ga-NOTA-SNA002

Phase 1 Completed

17 enrolled

Other solid neoplasm

Solid Tumor

Clinical Trials

Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma

A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers

Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors

S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers

A Study of KL340399 in Patients With Advanced Solid Tumors

A Study of Intratumoral KL340399 in Patients With Advanced Solid Tumors

AMG 510 Ethnic Sensitivity Study (CodeBreaK 105).

First in Human Study of M6223

A Study Evaluating the Safety, Tolerance and Anti-tumor Activity of HBM1020 in Subjects With Advanced Solid Tumors

A Phase 1 Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HH-101 in Patients With Advanced Solid Tumors

ProAgio in Previously Treated Advanced Pancreatic Cancer and Other Solid Tumor Malignancies

Study to Assess the Safety & Tolerability of NOV140101(IDX-1197) in Patients With Advanced Solid Tumors

Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies

LuPARP

A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors

Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients

Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery

TORERO

A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors

A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus

Phase Ia/Ib Study of RS-0139 in Patients With a Recurrent, Locally Advanced or Metastatic Solid Tumors

A Phase 1 Study of SAIL66 in Patients With CLDN6-positive Locally Advanced or Metastatic Solid Tumors

Safety, Tolerability and Pharmacokinetics of AZD1775 (Adavosertib) Plus MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumours

Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid Tumors

A Study to Test the Safety of the Investigational Drug Larotrectinib in Adults That May Treat Cancer

Assessment of Safety, Tolerability and PK Profile of MSP008-22 in Patients With Advanced Solid Tumours

A Study in People With Advanced Cancer to Test Whether the Amount of BI 907828 in the Blood is Influenced by Taking an OATP Inhibitor or a CYP3 Inhibitor

PEMBIB

A First-in-Human Study of JAB-8263 in Adult Patients With Advanced Solid Tumors

A Phase 1b/2 Study of ADG116, ADG116 Combined With Anti-PD-1 Antibody or Anti-CD137 Antibody in Solid Tumors Patients

Study of the Safety and Pharmacokinetics of BGB-283 (Lifirafenib) and PD-0325901 (Mirdametinib) in Participants With Advanced or Refractory Solid Tumors

First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study

A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection

Study of ZGGS15 in Patients With Advanced Solid Tumors

RAPIRI

A Study of NB003 in Patients With Advanced Malignancies

Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers

A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC61in Subjects With Advanced Solid Tumors

Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumor Patients in China

Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT1308 in Advanced Solid Tumors

A Study of BR101 Injection Alone in Subjects With Advanced Solid Tumors

HCW9218 in Select Advanced Solid Tumors

Study of AMG 256 in Adult Subjects With Advanced Solid Tumors

Study to Evaluate the Effect of Bosentan on the Pharmacokinetics of Lurbinectedin in Patients With Advanced Solid Tumors

A Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]IMP4297 to China Healthy Male Subjects

An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fasting Condition

An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fed Condition

Phase I Clinical Trial of 68Ga-NOTA-SNA002